Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Bruker (BRKR) over the last 16 years, with Q3 2025 value amounting to $20.9 million.

  • Bruker's Capital Expenditures fell 3588.96% to $20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.9 million, marking a year-over-year decrease of 472.3%. This contributed to the annual value of $115.3 million for FY2024, which is 785.78% up from last year.
  • As of Q3 2025, Bruker's Capital Expenditures stood at $20.9 million, which was down 3588.96% from $21.3 million recorded in Q2 2025.
  • Bruker's 5-year Capital Expenditures high stood at $57.7 million for Q3 2022, and its period low was $16.3 million during Q3 2021.
  • Its 5-year average for Capital Expenditures is $26.9 million, with a median of $24.7 million in 2021.
  • In the last 5 years, Bruker's Capital Expenditures surged by 25398.77% in 2022 and then crashed by 5337.95% in 2023.
  • Bruker's Capital Expenditures (Quarter) stood at $28.4 million in 2021, then increased by 21.83% to $34.6 million in 2022, then fell by 8.96% to $31.5 million in 2023, then rose by 16.51% to $36.7 million in 2024, then tumbled by 43.05% to $20.9 million in 2025.
  • Its Capital Expenditures stands at $20.9 million for Q3 2025, versus $21.3 million for Q2 2025 and $26.0 million for Q1 2025.